Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...
Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its ...
An employee at a daycare in Georgia was filmed aggressively changing a child's diaper before tossing him into scalding water.
Parents or caregivers could reliably make anthropometric measurements such as height, weight, and head circumference.
The Trump administration’s efforts to claw back federal grant money, led by the world’s richest person, will affect access to ...
In a cohort of more than 11,000 patients from the U.K. and Ireland, a comparable proportion of new adalimumab users achieved ...
The FDA approved tislelizumab-jsgr (Tevimbra) with platinum chemotherapy as a first-line treatment for adults with ...
Adults with a history of depression gained long-term physical health conditions at a rate 30% faster than those without such ...
Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...
A report from Rice University’s Kinder Institute for Urban Research shows Spring ISD's pre-K programs improved Kindergarten readiness and decreased chronic absenteeism for Kindergarteners and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback